Stem-loop Primer with UMI for Cell-free Nucleic Acid Isolation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The small size of circulating cell-free nucleic acids such as cfDNA poses challenges for traditional sequencing and amplification protocols.

Innovation Solution

The use of a stem-loop primer with a unique molecular identifier (UMI) that comprises a 5′ arm sequence complementary to the first end region, a stem-loop sequence containing the UMI, and a 3′ arm sequence complementary to the second end region, allowing for improved isolation and amplification of cell-free nucleic acids.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional sequencing and amplification protocols are used, then the process is simple and well-established, but the small size of circulating cell-free nucleic acids poses challenges that reduce effectiveness

Engineering Contradiction:
Improveeffectiveness of sequencing and amplificationVSAvoidcomplexity of protocol
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The protocol is divided into distinct stages: isolation using magnetic beads, amplification using stem-loop primers, and sequencing. Each stage is optimized independently to handle the specific challenges of small-sized cfNA molecules, improving overall reliability without requiring complete protocol redesign

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Magnetic beads serve as an intermediary to isolate cfNA molecules from complex biological samples. The beads bind to the nucleic acids through specific interactions, enabling selective capture and concentration of small cfNA molecules that would otherwise be difficult to handle with traditional methods

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If stem-loop primers with UMI are used, then isolation and amplification efficiency is improved, but the primer design and reaction conditions become more complex

Engineering Contradiction:
Improveisolation and amplification efficiencyVSAvoidprimer design complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The stem-loop primer design serves multiple functions simultaneously: the stem-loop structure enables specific binding to cfNA, the UMI provides molecular identification for quantification, and the overall structure facilitates efficient amplification. This multi-functionality improves productivity while managing design complexity through integrated functionality

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The primer design incorporates specific parameter optimizations including stem-loop structure geometry, UMI sequence composition, and hybridization temperature conditions. These parameter changes are systematically adjusted to maximize amplification efficiency for small cfNA molecules while maintaining manageable design complexity

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If cfNA are isolated and amplified, then diagnostic capability for conditions like cancer and metabolic diseases is enhanced, but the processing time and resource requirements increase

Engineering Contradiction:
Improvediagnostic capabilityVSAvoidprocessing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

Magnetic bead isolation is performed as a preliminary step to concentrate and purify cfNA molecules before amplification. This preliminary action reduces the complexity of subsequent steps and enables faster processing by starting with a pre-concentrated template, thereby reducing overall processing time while maintaining diagnostic precision

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables efficient processing and sequencing of cell-free nucleic acids, enhancing the ability to diagnose and characterize conditions such as cancer, trauma, and metabolic diseases.

Implementation Method 1

a 5′ arm sequence configured to hybridize to a complementary first end region of said target sequence; a 3′ arm sequence configured to hybridize to a second end region of said target sequence

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS20250034640A1Compositions and methods for cell-free nucleic acid isolation
Publication Date: 2025.01.30 SIMSEN DIAGNOSTICS AB
  • US20250034640A1 patent drawing
  • US20250034640A1 patent drawing
  • US20250034640A1 patent drawing

AI summary

Provided herein are methods and compositions for improved isolation and amplification of nucleic acids.